Latest news with #Zepbound
Yahoo
8 hours ago
- Health
- Yahoo
HealthRX Expands Telehealth Website Experience to Include GLP-1 Weight Loss Solutions, Prescription Access, and 24/7 Wellness Support
HealthRX enhances online platform to offer doctor-prescribed GLP-1 medications like Ozempic® and Zepbound® for adults seeking virtual weight loss support, prescription access, and 24/7 telehealth care BROOKLYN, June 19, 2025 (GLOBE NEWSWIRE) -- HealthRX, a digital health platform serving adults across the United States, has announced an expanded online experience designed to support weight management and long-term wellness through a suite of integrated offerings. These include Health RX Telehealth™, Health RX Prescription Access™, and Health RX Wellness Support™, all accessible through its newly enhanced website at The update provides streamlined access to GLP-1 medications such as Ozempic®, Zepbound®, and compounded alternatives—subject to eligibility criteria and clinical discretion. The HealthRX platform is built to accommodate adults who are seeking a secure, doctor-supervised weight management option that minimizes barriers to care and supports routine-friendly wellness. A Digital Health Platform Designed for Results HealthRX offers a simplified path for adults to explore medically appropriate weight loss options from the comfort of home. Through the HealthRX intake process, users can connect with U.S.-licensed physicians to determine clinical eligibility for GLP-1 medications. The program emphasizes convenience and flexibility, removing the need for in-person consultations or insurance requirements. The platform's design integrates: Health RX Telehealth™ – Secure access to virtual consultations with board-certified physicians. Health RX Prescription Access™ – Direct, encrypted coordination with pharmacies for prescription fulfillment and renewals. Health RX Wellness Support™ – A collection of tools including coaching support, educational resources, medication reminders, and outcome tracking. Each service is built to align with common adult health goals—particularly those related to sustained weight management. Full details are available on the official HealthRX website at Highlight on GLP-1 Medication Access: Ozempic®, Zepbound®, and Tirzepatide Options GLP-1 medications have emerged as a physician-supervised option for individuals managing obesity or weight-related conditions. HealthRX facilitates access to FDA-approved GLP-1 treatments such as Ozempic®, Zepbound®, and Tirzepatide®, as well as compounded GLP-1 or GLP-1/GIP medications based on clinical suitability. These medications work by targeting appetite regulation and glucose control pathways and are prescribed in accordance with FDA labeling or compound-specific clinical judgment. The HealthRX platform outlines potential usage scenarios, average pricing tiers, and expected timelines for prescription delivery—all while emphasizing that outcomes vary by individual. For medication access information, visit HealthRX also confirms that compounded medications offered through the platform are prepared in U.S.-based facilities in accordance with USP <795> and <797> standards. The company notes that compounded drug products are not FDA-approved, and eligibility is determined during the virtual consultation process with a licensed provider. Three-Step Process Designed for Accessibility Visitors to the website are guided through a simple three-step intake process: Take the Assessment – Users begin by completing a short clinical questionnaire to determine preliminary eligibility. Meet a Board-Certified Physician – Within 24 hours, eligible users are connected to a licensed medical provider for an evaluation. Receive Medication – Upon approval, GLP-1 prescriptions are delivered securely to the patient's door with ongoing support available. This process is designed to make adult wellness and weight loss support accessible without long wait times, insurance hassles, or frequent office visits. A full description is provided at Pricing and Support Structure As listed on the platform: Ozempic® (Brand GLP-1) – $1,299/month (In Stock) Tirzepatide® (GLP-1 + GIP) – $1,299/month (Limited Stock) GLP-1 Injections (Compounded) – $189/month (Low Stock) GLP-1 Oral Tablets (Compounded) – $239/month (Low Stock) GLP-1 + GIP Injection (Compounded) – $349/month (In Stock) Pricing reflects bundled services that include medical evaluation, platform access, prescription coordination, and support. Details and plan tiers are explained at Transparent Clinical Oversight All HealthRX-affiliated physicians are U.S.-licensed and board-certified in relevant specialties such as internal medicine, emergency care, osteopathic medicine, and family medicine. Provider credentials and bios are available through the HealthRX platform. HealthRX confirms that all consultations, messaging, and record keeping are conducted through encrypted channels in compliance with HIPAA regulations. Privacy and user consent policies are explained at Health RX Wellness Support™ Adds a Preventive Layer Health RX Wellness Support™ complements prescription and telehealth services by offering educational and lifestyle tools, including: Digital health journals and medication tracking Reminder alerts for check-ins and prescription refills Curated content on nutrition, movement, and self-care Access to secure provider messaging These tools aim to reinforce adherence and increase long-term success for adults pursuing medically guided weight loss. More about the support program can be found at Verified Customer Experiences HealthRX highlights verified user reviews collected by third-party platforms: "Signing up took less than five minutes, and the process was clear." "The support staff answered every question. I already feel healthier." "After starting the treatment, I received my delivery within 48 hours." Individual experiences are unique, and HealthRX maintains a strict no-guarantee policy regarding outcomes. Additional testimonials and review information are linked from Platform Policies and Consumer Disclosures HealthRX outlines its key platform policies, including: No charge if a user does not qualify Cancellation is available anytime without penalties Refunds are processed within 24–48 hours if eligibility is not met Insurance is not required but may be used independently for reimbursement These policies are detailed in the platform's Terms of Service and FAQ sections at About HealthRX HealthRX is a U.S.-based virtual healthcare platform offering GLP-1-based weight management, online prescription access, and ongoing support through secure telehealth services. The platform includes Health RX Telehealth™, Health RX Prescription Access™, and Health RX Wellness Support™, designed to provide adults with personalized, remote wellness strategies. HealthRX is not a healthcare provider itself, but coordinates licensed services through verified clinical partners. More about the HealthRX platform can be found at Product and Contact Information Products and Services: Health RX Telehealth™ Health RX Prescription Access™ Health RX Wellness Support™ GLP-1 Medications: Ozempic®, Zepbound®, Tirzepatide®, Compounded Options Website: Contact Email: support@ +1 (208) 494-2534 Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results may vary. Consumers should consult a licensed medical provider for personalized recommendations. HealthRX does not guarantee eligibility, outcomes, or medication access. GLP-1 medications may cause serious side effects, including possible thyroid tumors. Do not use if you or a family member have a history of medullary thyroid carcinoma (MTC) or MEN 2. Compounded drugs are not FDA-approved, and their safety and effectiveness have not been evaluated by the FDA. HealthRX does not manufacture, prescribe, or dispense medication directly. All services are provided through licensed third parties. CONTACT: Email: support@ Phone: +1 (208) 494-2534Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Upturn
9 hours ago
- Health
- Business Upturn
HealthRX Expands Telehealth Website Experience to Include GLP-1 Weight Loss Solutions, Prescription Access, and 24/7 Wellness Support
BROOKLYN, June 19, 2025 (GLOBE NEWSWIRE) — HealthRX, a digital health platform serving adults across the United States, has announced an expanded online experience designed to support weight management and long-term wellness through a suite of integrated offerings. These include Health RX Telehealth™, Health RX Prescription Access™, and Health RX Wellness Support™, all accessible through its newly enhanced website at The update provides streamlined access to GLP-1 medications such as Ozempic®, Zepbound®, and compounded alternatives—subject to eligibility criteria and clinical discretion. The HealthRX platform is built to accommodate adults who are seeking a secure, doctor-supervised weight management option that minimizes barriers to care and supports routine-friendly wellness. A Digital Health Platform Designed for Results HealthRX offers a simplified path for adults to explore medically appropriate weight loss options from the comfort of home. Through the HealthRX intake process, users can connect with U.S.-licensed physicians to determine clinical eligibility for GLP-1 medications. The program emphasizes convenience and flexibility, removing the need for in-person consultations or insurance requirements. The platform's design integrates: Health RX Telehealth™ – Secure access to virtual consultations with board-certified physicians. – Secure access to virtual consultations with board-certified physicians. Health RX Prescription Access™ – Direct, encrypted coordination with pharmacies for prescription fulfillment and renewals. – Direct, encrypted coordination with pharmacies for prescription fulfillment and renewals. Health RX Wellness Support™ – A collection of tools including coaching support, educational resources, medication reminders, and outcome tracking. Each service is built to align with common adult health goals—particularly those related to sustained weight management. Full details are available on the official HealthRX website at Highlight on GLP-1 Medication Access: Ozempic®, Zepbound®, and Tirzepatide Options GLP-1 medications have emerged as a physician-supervised option for individuals managing obesity or weight-related conditions. HealthRX facilitates access to FDA-approved GLP-1 treatments such as Ozempic®, Zepbound®, and Tirzepatide®, as well as compounded GLP-1 or GLP-1/GIP medications based on clinical suitability. These medications work by targeting appetite regulation and glucose control pathways and are prescribed in accordance with FDA labeling or compound-specific clinical judgment. The HealthRX platform outlines potential usage scenarios, average pricing tiers, and expected timelines for prescription delivery—all while emphasizing that outcomes vary by individual. For medication access information, visit HealthRX also confirms that compounded medications offered through the platform are prepared in U.S.-based facilities in accordance with USP <795> and <797> standards. The company notes that compounded drug products are not FDA-approved, and eligibility is determined during the virtual consultation process with a licensed provider. Three-Step Process Designed for Accessibility Visitors to the website are guided through a simple three-step intake process: Take the Assessment – Users begin by completing a short clinical questionnaire to determine preliminary eligibility. Meet a Board-Certified Physician – Within 24 hours, eligible users are connected to a licensed medical provider for an evaluation. Receive Medication – Upon approval, GLP-1 prescriptions are delivered securely to the patient's door with ongoing support available. This process is designed to make adult wellness and weight loss support accessible without long wait times, insurance hassles, or frequent office visits. A full description is provided at Pricing and Support Structure As listed on the platform: Ozempic® (Brand GLP-1) – $1,299/month (In Stock) – $1,299/month (In Stock) Tirzepatide® (GLP-1 + GIP) – $1,299/month (Limited Stock) – $1,299/month (Limited Stock) GLP-1 Injections (Compounded) – $189/month (Low Stock) – $189/month (Low Stock) GLP-1 Oral Tablets (Compounded) – $239/month (Low Stock) – $239/month (Low Stock) GLP-1 + GIP Injection (Compounded) – $349/month (In Stock) Pricing reflects bundled services that include medical evaluation, platform access, prescription coordination, and support. Details and plan tiers are explained at Transparent Clinical Oversight All HealthRX-affiliated physicians are U.S.-licensed and board-certified in relevant specialties such as internal medicine, emergency care, osteopathic medicine, and family medicine. Provider credentials and bios are available through the HealthRX platform. HealthRX confirms that all consultations, messaging, and record keeping are conducted through encrypted channels in compliance with HIPAA regulations. Privacy and user consent policies are explained at Health RX Wellness Support™ Adds a Preventive Layer Health RX Wellness Support™ complements prescription and telehealth services by offering educational and lifestyle tools, including: Digital health journals and medication tracking Reminder alerts for check-ins and prescription refills Curated content on nutrition, movement, and self-care Access to secure provider messaging These tools aim to reinforce adherence and increase long-term success for adults pursuing medically guided weight loss. More about the support program can be found at Verified Customer Experiences HealthRX highlights verified user reviews collected by third-party platforms: 'Signing up took less than five minutes, and the process was clear.' 'The support staff answered every question. I already feel healthier.' 'After starting the treatment, I received my delivery within 48 hours.' Individual experiences are unique, and HealthRX maintains a strict no-guarantee policy regarding outcomes. Additional testimonials and review information are linked from Platform Policies and Consumer Disclosures HealthRX outlines its key platform policies, including: No charge if a user does not qualify Cancellation is available anytime without penalties Refunds are processed within 24–48 hours if eligibility is not met Insurance is not required but may be used independently for reimbursement These policies are detailed in the platform's Terms of Service and FAQ sections at About HealthRX HealthRX is a U.S.-based virtual healthcare platform offering GLP-1-based weight management, online prescription access, and ongoing support through secure telehealth services. The platform includes Health RX Telehealth™, Health RX Prescription Access™, and Health RX Wellness Support™, designed to provide adults with personalized, remote wellness strategies. HealthRX is not a healthcare provider itself, but coordinates licensed services through verified clinical partners. More about the HealthRX platform can be found at Product and Contact Information Products and Services: Health RX Telehealth™ Health RX Prescription Access™ Health RX Wellness Support™ GLP-1 Medications: Ozempic®, Zepbound®, Tirzepatide®, Compounded Options Website: Contact Email: [email protected] Phone: +1 (208) 494-2534 Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results may vary. Consumers should consult a licensed medical provider for personalized recommendations. HealthRX does not guarantee eligibility, outcomes, or medication access. GLP-1 medications may cause serious side effects, including possible thyroid tumors. Do not use if you or a family member have a history of medullary thyroid carcinoma (MTC) or MEN 2. Compounded drugs are not FDA-approved, and their safety and effectiveness have not been evaluated by the FDA. HealthRX does not manufacture, prescribe, or dispense medication directly. All services are provided through licensed third parties. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
BBC News
17 hours ago
- Business
- BBC News
US demand for weight loss drugs drives Irish exports
A huge surge in Ireland's goods exports in the first quarter of 2025 was partially due to demand for weight loss drugs in the United States, the central bank in Dublin has said. The main reason for the big rise in Irish exports was businesses getting goods into the US before President Donald Trump's tariffs took effect in April. March was a record month for Irish exports to the US with sales worth $25bn (£18.7bn), 400% higher than the same period in 2024. The Central Bank of Ireland said this surge was "concentrated in a single product category: ingredients used in weight loss and diabetes medicines". It added that when the tariff effect was stripped out there was "some evidence of strong momentum in underlying goods exports related to weight loss products, ingredients for which are manufactured in Ireland". "The pharmaceutical sector in Ireland appears well placed to take advantage of rapidly rising global demand for these products." Weight loss drugs manufactured in Ireland The US firm Eli Lilly makes the active pharmaceutical ingredients for its Zepbound and Mounjaro weight loss treatments near Kinsale in County Cork. Earlier this decade it invested $800m (£597m) in the Cork facility to help meet anticipated demand for the drug. Eli Lilly said in the first quarter of 2025 its sales of the drugs were worth just over $6bn (£4.5bn) compared to $2.3bn (£1.7bn) in the same period in 2024. Zepbound and Mounjaro are among a class of drugs which work as an appetite suppressant by mimicking a hormone called glucagon-like peptide-1 (GLP-1). This is an intestinal hormone which is released after eating, and typically makes people feel fuller. Most of the US's major pharmaceutical companies have manufacturing operations in Ireland, partially for tax reasons. That has made the US Ireland's biggest export market with pharmaceuticals the most important sector. Trump has not yet imposed tariffs on pharmaceuticals but is threatening to do so on national security grounds. Until that happens the majority of Irish goods exported to the US do not face tariffs.
Irish Post
a day ago
- Business
- Irish Post
Weight loss drugs lead to a surge in Irish exports to America
ACCORDING to the Central Bank of Ireland, the US' growing demand for weight-loss drugs have led to a massive rise in exports in the first half of the year. Companies racing to export to the US before Trump's tariffs take effect are the major reason for the spike. March marked a record month, with $25bn in exports to the US - a fourfold increase from March 2024. The bank noted this spike was centred on one product category: ingredients used in weight loss and diabetes medications. Even without the tariff-related rush, strong demand for these pharmaceutical ingredients - many produced in Ireland - continues to fuel export growth. US drugmaker Eli Lilly, which produces the active ingredients for Zepbound and Mounjaro in County Cork, invested $800m in the site to expand capacity. Its first quarter sales of the drugs exceeded $6bn, up from $2bn a year ago. These drugs work by suppressing appetite by mimicking the GLP-1 hormone, which helps people feel full after eating. Many US pharmaceutical giants manufacture in Ireland, attracted by favourable tax policies, making the US Ireland's largest export market and pharmaceuticals its top export. While Trump has yet to impose tariffs on pharmaceuticals, he has suggested doing so for national security reasons. For now, most Irish exports to the US remain tariff-free. See More: Economy, Eli Lilly, Irish Exports, Mounjaro, Ozempic, Weight Loss
BBC News
a day ago
- Business
- BBC News
Weight loss drug demand in US drives Ireland's exports
A huge surge in Ireland's goods exports in the first quarter of 2025 was partially due to demand for weight loss drugs in the United States, the central bank in Dublin has main reason for the big rise in Irish exports was businesses getting goods into the US before President Donald Trump's tariffs took effect in was a record month for Irish exports to the US with sales worth $25bn (£18.7bn), 400% higher than the same period in Central Bank of Ireland said this surge was "concentrated in a single product category: ingredients used in weight loss and diabetes medicines". It added that when the tariff effect was stripped out there was "some evidence of strong momentum in underlying goods exports related to weight loss products, ingredients for which are manufactured in Ireland"."The pharmaceutical sector in Ireland appears well placed to take advantage of rapidly rising global demand for these products." Weight loss drugs manufactured in Ireland The US firm Eli Lilly makes the active pharmaceutical ingredients for its Zepbound and Mounjaro weight loss treatments near Kinsale in County this decade it invested $800m (£597m) in the Cork facility to help meet anticipated demand for the Lilly said in the first quarter of 2025 its sales of the drugs were worth just over $6bn (£4.5bn) compared to $2.3bn (£1.7bn) in the same period in and Mounjaro are among a class of drugs which work as an appetite suppressant by mimicking a hormone called glucagon-like peptide-1 (GLP-1).This is an intestinal hormone which is released after eating, and typically makes people feel fuller. Most of the US's major pharmaceutical companies have manufacturing operations in Ireland, partially for tax has made the US Ireland's biggest export market with pharmaceuticals the most important has not yet imposed tariffs on pharmaceuticals but is threatening to do so on national security that happens the majority of Irish goods exported to the US do not face tariffs.
